Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05279651 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

Study acronym: PREVENT-MINS
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv22
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 2500 to confirmed 2146
    • Primary completion date: Mar 15, 2025 to Apr 30, 2025
    • Site details revised at 26 of 26 sites
    v21
  3. Site details revised at 1 of 26 sitesv20
  4. Study sites: 25 to 26
    • Study completion date: Mar 31, 2026 to Jun 30, 2026
    v19
  5. Site details revised at 1 of 25 sitesv18
Show 16 earlier versionsHide 16 earlier versions
  1. Site details revised at 1 of 25 sitesv17
  2. Site details revised at 3 of 25 sitesv16
  3. Study sites: 22 to 25v15
  4. Secondary endpoints: 15 to 17
    • Site details revised at 1 of 22 sites
    v14
  5. Site details revised at 3 of 22 sitesv13
  6. Site details revised at 1 of 22 sitesv12
  7. Site details revised at 2 of 22 sitesv11
  8. Site details revised at 1 of 22 sitesv10
  9. Site details revised at 1 of 22 sitesv9
  10. Site details revised at 1 of 22 sitesv8
  11. Study sites: 21 to 22v7
  12. Study sites: 20 to 21v6
  13. Study sites: 19 to 20v5
  14. Lead sponsor: Wojciech Szczeklik to Jagiellonian Universityv4
  15. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 16 to 19
    • Start date changed from estimate of May 2022 to Jun 13, 2022
    v3
  16. Lead sponsor: Jagiellonian University to Wojciech Szczeklik
    • Start date: Mar 15, 2022 to May 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a multicentre, randomized controlled trial of ivabradine versus placebo.
Trial Details
NCT Number NCT05279651
Lead Sponsor Jagiellonian University
Collaborators: Population Health Research Institute, Vanderbilt University Medical Center
Conditions
(from sponsor)		 Myocardial Injury After Noncardiac Surgery (MINS), Myocardial Ischemia
Related terms Cardiovascular Diseases, Myocardial Ischemia
Enrollment 2,146 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov